Admission Date:  [**2173-5-31**]              Discharge Date:   [**2173-6-9**]  Date of Birth:  [**2135-11-15**]             Sex:   F  Service: MEDICINE  Allergies: Prochlorperazine  Attending:[**First Name3 (LF) 3918**] Chief Complaint: Cough, SOB  Major Surgical or Invasive Procedure: None  History of Present Illness: 37 year old female with a history of ALL, s/p allo SCT [**1-13**] c/b neutropenic fever and skin GVHD, presents with one day of shortness of breath and cough.
Blood cultures were drawn, nasal swab sent for viral screen, and she was given cefepime IV 2g and admitted for fever.
-Aspirate Smear: >90% cellularity, interstitial infiltrate of immature cells consistent with blasts in sheets occupying 95% of  marrow cellularity.
-Immunophenotyping (Flow cytometry:) Positive: CD34 (subset 32%,) HLA-DR, TdT, 19 CD15 (subset 52%) Negative: CD20, CD10 CD13, CD33, CD14, CD117, CD64, CD11c and CD56 -Dx = Precursor B-cell ALL -Cytogenetics: --Some aberrations (including trisomy 22) seen in single metaphase.
--FISH: Ph-negative, abnormal pattern in 60/100 cells indicative of trisomy 22, abnormal MLL rearrangement in 90/100 cells INDUCTION: Phase I, weeks [**2-8**], day 1 = [**2172-8-13**] Daunorubicin 60 mg/m2 iv day 1, 8, 15 and 22 Vincristine 1.4 mg/m2 iv day 1, 8, 15 and 22 Dexamethasone 10 mg iv tid day [**3-4**] L-Asparaginase 10,000 IU day 17-28 MTX 12.5 mg IT day 8 (instead of day 15) -CSF = rare atypical mononuclear cells, favor atypical lymphocytes.
Cytarabine 75 mg/m2 = 130 mg IV Days [**2-8**], [**9-15**], 15-18, 22-25 Mercaptopurine 60 mg/m2 = 100 mg Day [**3-4**] MTX 12.5 mg IT Days 1, 8, 15, 22 Response Evaluation: Bone Marrow Aspirate/Biopsy on [**10-26**] CR: -No morphologic evidence of residual leukemia -Normal cytogenetics, negative FISH for MLL Intensification Therapy 3 cycles of HD-MTX 3 g/m2 days 1 ([**11-26**]-given), 8, and 22 Standard Leucovorin rescue L-asparaginase 10,000 IU days 2 ([**11-27**]-given,) 9, and 23 Allogenic Double Cord Blood SCT Conditioning was achieved with Fludarabine, and Ara-C and TBI.
Ciprofloxacin, Fluticasone and Acyclovir were initiated for prophylaxis as per protocol.
Family History: Mother had gastric cancer  Physical Exam: VS: T 101.0 BP 136/94 HR 109 RR 40 SpO2 86/RA -> 94%/4L General: African American Female in moderate distress, tachypneic CV: RRR, no m/r/g, JVP not elevated, 2+ pulses DP Resp: diffuse rhonchi bilaterally, worse at right base Abd: NT, ND, BS+ Ext: No edema, warm well perfused Neuro: AAO x 3, speech fluent, no pronator drift   Pertinent Results: Admission Labs:  Chemistries: UREA N-9 CREAT-1.0 SODIUM-143 POTASSIUM-3.7 CHLORIDE-107 TOTAL CO2-28 ANION GAP-12 ALT(SGPT)-9 AST(SGOT)-21 ALK PHOS-84 TOT BILI-1.0 CALCIUM-8.5 PHOSPHATE-3.3 MAGNESIUM-1.6 tacroFK-8.8  CBC: WBC-8.4 RBC-2.88* HGB-9.1* HCT-28.5* MCV-99* MCH-31.6 MCHC-32.0 RDW-16.4* Diff: NEUTS-64 BANDS-0 LYMPHS-26 MONOS-9 EOS-1 BASOS-0 ATYPS-0 METAS-0 MYELOS-0 HYPOCHROM-2+ ANISOCYT-1+ POIKILOCY-1+ MACROCYT-2+ MICROCYT-NORMAL POLYCHROM-NORMAL OVALOCYT-2+ PLT SMR-LOW PLT COUNT-104*  [**2173-6-1**] 1:40 am BRONCHOALVEOLAR LAVAGE                              **FINAL REPORT [**2173-6-17**]**     GRAM STAIN (Final [**2173-6-1**]):       1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR LEUKOCYTES.
POTASSIUM HYDROXIDE PREPARATION (Final [**2173-6-1**]):       This is a low yield procedure based on our in-house studies.
Left PICC tip projects over the mid/lower SVC.
Upon admission to the floor, she was transferred to the MICU for ongoing respiratory distress and urgent bronchoscopy with extensive infiltrates seen on CT Chest.
She received vancomycin and cefepime prior to admission to the ICU and also underwent a CTA chest that was negative for PE.
She was continued on vancomycin and cefepime.
She was started on bactrim IV as empiric PCP [**Name Initial (PRE) 31304**].
BAL culture grew Psudomonas aerginoasa sensitive to Cefepime and CIprofloxacin.
She was switched to a combination of Cefepime and Ciprofloxacin for double Abx coverage for Pseudomonas.
The patient was also continued on PO Voriconazole in place of Caspofungin.
She is being discharged home to complete a 14 day total Abx course of Cefepime and Ciprofloxacin.
She will continue Prednisone at 10mg daily upon discharge and will follow-up with her oncologist Dr. [**Last Name (STitle) **].
We also continued folic acid.
GERD: reports occoasional symptoms for which she takes omeprazole daily, which was continued while in hospital  Medications on Admission: acyclovir 400mg PO tid atovaquone 1500mg PO daily enzonatate 100mg PO tid carvedilol 37.5 mg PO bid advair 500/50 INH [**Hospital1 **] Folic Acid 1mg PO daily Cellcept 250mg PO bid Omeprazole 20mg PO daily Prednisone 10mg PO daily Tacrolimus 0.25mg PO bid Voriconazole 200mg PO q 12 Mag Oxide 133mg PO tid MVI 1 tab daily   Discharge Medications: 1.
Cefepime 2 gram Recon Soln Sig: One (1) Recon Soln Injection Q12H (every 12 hours) for 6 days: Last day = [**2173-6-15**] in AM.
Prednisone 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily): Until directed otherwise by Dr. [**Last Name (STitle) **].
Ciprofloxacin 750 mg Tablet Sig: One (1) Tablet PO every twelve (12) hours for 9 days: Last day = [**2173-6-18**].
Mycophenolate Mofetil 250 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Tacrolimus 0.5 mg Capsule Sig: 0.5 Capsule PO Q12H (every 12 hours).
Acyclovir 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours).
Voriconazole 200 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours).
Omeprazole 20 mg Capsule, Delayed Release(E.C.)
Atovaquone 750 mg/5 mL Suspension Sig: One (1)  PO DAILY (Daily).
Valsartan 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Carvedilol 12.5 mg Tablet Sig: Three (3) Tablet PO BID (2 times a day).
Benzonatate 100 mg Capsule Sig: One (1) Capsule PO TID (3 times a day).
Magnesium Oxide 84.5 mg (140 mg) Capsule Sig: One (1) Capsule PO three times a day.
Disp:*1 disk* Refills:*2*   Discharge Disposition: Home With Service  Facility: Critical Care Systems  Discharge Diagnosis: Primary: pneumonia  Secondary: ALL status post allogeneic stem cell trasnplant   Discharge Condition: Mental Status: Clear and coherent.
We performed a procedure called bronchosopy to evaluate the cause of your pneumonia.
At this time, you no longer require oxygen and are able to walk without getting short of breath.
You will need to complete a course of antibiotics as follows:  We STARTED you on Cefepime 2 grams IV every 12 hours.
Please continue to take all your other medications as prescribed.
